Point-of-Care Ultrasonography in the Critical Care Unit: An Update.

Publication date: Feb 15, 2025

This article outlines updates in point of care ultrasonography. Improving diagnostic accuracy and image quality is continuing to evolve in Point-of-care ultrasonography (POCUS). This include incorporating Artificial Intelligence (AI) and use of other modalities such as Doppler in lung ultrasonography. Transesophageal echocardiography is an emerging option when imaging is difficult to obtain via transthoracic echocardiography. POCUS is becoming instrumental when used during cardiac arrest. Ultrasound (VExUS) Grading System is a promising measurement to assess a patient’s volume status. Given the multiple advantages of POCUS usage, competency in POCUS became a requirement of Critical Care fellowship training. POCUS is an important diagnostic modality and guide to medical management. New technological advances such as AI, can serve as a guide to enhance image quality and help accurately obtain quantitative assessments. POCUS has a major role during cardiac arrest and advanced cardiac life support. The clinical utility of POCUS was further substantiated during the COVID-19 pandemic. The Accreditation Council for Graduate Medical Education (ACGME) requires critical care programs to include competency in POCUS as part of their training.

Open Access PDF

Concepts Keywords
Arrest Artificial intelligence
Covid COVID-19
Echocardiography Critical Care
Improving Critical care ultrasonography
Pandemic Echocardiography
Echocardiography
Heart Arrest
Humans
Intensive Care Units
POCUS
Point-of-Care Systems
Point-of-care ultrasonography
SARS-CoV-2
Ultrasonography
Update

Semantics

Type Source Name
disease IDO quality
disease MESH cardiac arrest
disease IDO role
disease MESH COVID-19 pandemic
disease MESH cardiogenic shock
disease MESH shock
disease MESH etiology
disease MESH respiratory failure
disease MESH edema
disease MESH pulmonary edema
disease MESH pneumonia
disease MESH atelectasis
drug DRUGBANK Medical air
disease MESH tension pneumothorax
disease MESH thrombosis
drug DRUGBANK Epinephrine
disease MESH emergency
drug DRUGBANK Coenzyme M
disease MESH hypovolemia
drug DRUGBANK Trestolone
drug DRUGBANK Isoxaflutole
drug DRUGBANK Etoperidone
disease MESH critically ill
disease MESH venous congestion
pathway REACTOME Reproduction
drug DRUGBANK Cilnidipine
disease IDO intervention
disease MESH hypotension
disease MESH out of hospital cardiac arrest
drug DRUGBANK Pearl (hyriopsis cumingii)
disease MESH Complications
drug DRUGBANK Acetohydroxamic acid

Original Article

(Visited 1 times, 1 visits today)